Siqing Fu, MD, PHD
M.D. Anderson Cancer Center · UT MD Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Siqing Fu, MD, PHD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:50 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06576037 · Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial OriginM.D. Anderson Cancer Center · recruiting · Solid Tumor · principal investigator
- Ph1NCT06365918 · Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With CarcinomatosisM.D. Anderson Cancer Center · withdrawn · Advanced Solid Tumor, Carcinomatosis · principal investigator
- Ph1NCT05431582 · Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid TumorsM.D. Anderson Cancer Center · withdrawn · Tumors, Ovarian Cancer, Breast Cancer · principal investigator
- Ph1NCT05300438 · Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.Tyligand Bioscience (Shanghai) Limited · unknown · Cancer (With or Without Metastasis) · principal investigator
- Ph1/Ph2NCT04902040 · Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesM.D. Anderson Cancer Center · terminated · Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Neoplasm · principal investigator
- Ph1NCT04711161 · First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.Green3Bio, Inc. · suspended · Ovarian Tumors · principal investigator
- Ph1NCT02812056 · Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated MalignanciesM.D. Anderson Cancer Center · withdrawn · Malignant Neoplasms of Digestive Organs, Malignant Neoplasms of Female Genital Organs, Malignant Neoplasms of Lip Oral Cavity and Pharynx · principal investigator
- Ph1NCT02042989 · MLN9708 and Vorinostat in Patients With Advanced p53 Mutant MalignanciesM.D. Anderson Cancer Center · completed · Advanced Cancers · principal investigator
- Ph1NCT01339871 · Study of Pazopanib and Vorinostat in Patients With Advanced MalignanciesM.D. Anderson Cancer Center · completed · Advanced Cancer · principal investigator
- Ph1NCT01200004 · Study of Grifola Frondosa (Maitake), Azacitidine, and LenalidomideM.D. Anderson Cancer Center · terminated · Advanced Cancers · principal investigator
- Ph1NCT01178112 · Trientine and Carboplatin in Advanced MalignanciesM.D. Anderson Cancer Center · completed · Advanced Cancers · principal investigator
- Ph1NCT00732836 · Hepatic Arterial Infusion (HAI) of AbraxaneM.D. Anderson Cancer Center · completed · Liver Cancer, Advanced Cancers, Solid Tumors · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.